170425 ⎘
Assays involving biological materials from specific organisms or of a specific nature from animals; from humans; Assays involving cytokines; Interleukins [IL] IL-6
SEMI-QUANTITATIVE LATERAL FLOW DEVICE AND METHOD FOR DETECTING BIOMARKERS IN UNPROCESSED SALIVA
#2PHARMACOKINETIC MODELING SYSTEMS FOR IMPROVED THERAPEUTIC DOSING
#3CD11B AGONISTS FOR TREATMENT OF AUTOIMMUNE DISEASE
#4METHODS AND SYSTEMS FOR RAPID DETECTION OF STROKE AND DETERMINATION OF ONSET VIA NEUROINFLAMMATION BIOMARKERS
#5N-TERMINAL MULTIFUNCTIONAL CONJUGATION OF PROTEINS AND PEPTIDES (FOR BIOSENSING)
#6PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF NEUROLOGICAL DISEASES COMPRISING HIGHLY POTENT STEM CELLS EXPRESSING TIMP-1, MCP-1, GROa, AND IL-6, AND METHOD FOR SELECTING HIGHLY POTENT STEM CELLS
#7Ultrasensitive Protein Detection using a Proximity Immunoassay with Nucleic Acid Target Amplification and Photonic Resonator Absorption Microscopy (PINATA)
#8METHOD FOR SCREENING AND PREPARING IMMUNOMODULATOR
#9ANAKINRA FOR THE TREATMENT OF POST ACUTE COVID SYNDROME
#10METHODS OF DETECTING AND TREATING CEREBRAL ANEURYSMS
#11METHODS FOR TREATING AND REDUCING TRAUMATIC BRAIN INJURY- ASSOCIATED IMPAIRMENTS USING SGP130
#12MMP-14 OR TIMP POTENCY ASSAY FOR MESENCHYMAL STEM CELLS
#13TRIPLE COMBINATION CANCER THERAPY WITH ANTI-PVRIG ANTIBODIES, ANTI-TIGIT ANTIBODIES, AND PEMBROLIZUMAB
#14MOUSE MODELS OF CYTOKINE RELEASE SYNDROME
#15METHODS OF DETECTING AND TREATING CEREBRAL ANEURYSMS
#16SYSTEM FOR DETECTING INFECTION IN SYNOVIAL FLUID
#17NOVEL CYTOKINE-BASED THERAPIES AND METHODS
#18Method of Peptide Library Construction and Peptides Thereof
#19BIOMARKER-BASED TREATMENT AND DIAGNOSTIC METHODS FOR IL-17-DEPENDENT CONDITIONS
#20NITRILOTRIACETIC ACID LINKERS, SOLID PHASE SYNTHESIS OF NITRILOTRIACETIC ACID LINKERS AND APPLICATIONS THEREOF
#21METHOD OF CHARACTERIZING TUMORS
#22MARKERS FOR PROGRESSION OF INFLAMMATORY LIVER DISEASE
#23Compounds
#24METHODS OF USING AVERMECTIN COMPOSITIONS FOR THE TREATMENT OF NEUROLOGICAL DISORDERS AND DOSING REGIMENS
#25NANOSENSORS AND USE THEREOF
#26USE OF GAMMA PRIME FIBRINOGEN AS A BIOMARKER IN THE ASSESSMENT OF COVID-19 INFECTIONS AND PROGNOSIS OF SEVERE DISEASE
#27MARKER FOR SELECTING HIGH-QUALITY STEM CELLS, AND METHOD FOR SELECTING HIGH-QUALITY STEM CELLS USING SAME
#28METHODS AND RELATED ASPECTS FOR PERFORMING LABEL-FREE SINGLE-MOLECULE IMMUNOASSAYS
#29MONITORING INFLAMMATION STATUS
#30COMPOSITIONS AND METHODS FOR THE TREATMENT OF DEPRESSION
#31PRODUCTS AND USES THEREOF FOR PREDICTING THE SENSITIVITY OF A SUBJECT TO CANCER IMMUNOTHERAPY INVOLVING AN ANTI-PD(L)1 AND AN ANTI-ANGIOGENIC AGENT, AND FOR SELECTING OPTIMIZED THERAPY
#32COMPOSITIONS AND METHODS FOR THE TREATMENT OF DEPRESSION
#33DIAGNOSTICS OF MILD OR ADVANCED PERIODONTITIS BASED ON SALIVARY IL-1BETA AND MMP-9
#34BIOMARKER SIGNATURES INDICATIVE OF EARLY STAGES OF CANCER
#35PRODUCTS AND USES THEREOF FOR PREDICTING THE SENSITIVITY OF A SUBJECT TO CANCER IMMUNOTHERAPY AND FOR SELECTING OPTIMIZED THERAPY
#36COMPOSITION FOR TREATING SOLID MALIGNANT TUMOR, AND KIT FOR TREATING SOLID MALIGNANT TUMOR
#37PROTEIN SIGNATURES FOR DISTINGUISHING BETWEEN BACTERIAL AND VIRAL INFECTIONS
#38GENE EXPRESSION MARKERS AND TREATMENT OF MULTIPLE SCLEROSIS
#39EARLY DIAGNOSIS OF INFECTIONS
#40RED BLOOD CELL-DERIVED MAGNETIC IMMUNO-PARTICLE AND USE THEREOF
#41VAGUS NERVE STIMULATION PRE-SCREENING TEST
#42SCREENING DONOR LUNGS FOR LUNG TRANSPLANTATION
#43Methods, Assays and Systems for Detection of a Target Analyte
#44ANTI-HERV-W ENVELOPE PROTEIN ANTIBODY FOR USE IN THE TREATMENT OF PSYCHOTIC DISEASES
#45CONDUCTOMETRIC SENSOR FOR DETECTING A BIOANALYTE AND A METHOD FOR THE DETECTION THEREOF
#46Cardiovascular Disease
#47ANALYSIS OF VITREOUS SAMPLES TO GUIDE TREATMENT
#48TARGET MEASUREMENT
#49DRAIN FLUIDS FOR DISEASE DIAGNOSIS AND MONITORING
#50Blood Test to Screen Out Parkinson's Disease
#51IL6 MARKER PANELS FOR EARLY DETECTION OF SEPSIS
#52Precision Medicine Approach to Targeting Neurodegeneration
#53URINARY TRACT INFECTION DIAGNOSTIC
#54USE OF BIOMARKERS FOR PREDICTING THE CLINICAL AND/OR TREATMENT OUTCOME OF A HUMAN SUBJECT
#55DIAGNOSIS OF SEPSIS
#56METHODS FOR SYSTEMATICALLY ASSESSING LOCAL INFLAMMATION AND ACTIVE REPAIR
#57INFLAMMATORY CYTOKINES AND FATIGUE IN SUBJECT WITH A COMPLEMENT MEDIATED DISEASE
#58SYSTEMS AND METHODS FOR DETECTING CYTOKINES
#59TARGET TISSUE-SPECIFIC ANTIGEN-BINDING MOLECULE
#60HIGH DOSE NICOTINAMIDE ADENINE DINUCLEOTIDE (NAD) PRECURSOR REGIMENS FOR REDUCTION OF INFLAMMATION IN HUMAN PATIENTS WITH PREEXISTING INFLAMMATION
#61TYPE 2 CYTOKINES AS PREDICTORS OF DISEASE SEVERITY AND/OR AS THERAPEUTIC TARGETS FOR COVID-19
#62ASSESSMENT METHODS AND DIAGNOSTIC KIT FOR PREDICTING ACUTE ANTIDEPRESSANT RESPONSE AND REMISSION IN PATIENTS WITH DEPRESSIVE DISORDERS USING MULTIMODAL SERUM BIOMARKERS
#63DETECTING SEPSIS
#64PLASMON-ENHANCED FLUORO-DOT ASSAYS
#65BIOMARKERS FOR PREDICTING RESPONSE TO IL-6 ANTAGONIST IN COVID-19 PNEUMONIA
#66Biomarker of gingivitis diagnosis and treatment
#67TnT BASED DIAGNOSIS OF PAROXYSMAL ATRIAL FIBRILLATION
#68SYSTEM FOR DETECTING INFECTION IN SYNOVIAL FLUID
#69Biomarkers and Methods for Measuring and Monitoring Inflammatory Disease Activity
#70METHOD FOR DIAGNOSING AND TREATING FIBROMYALGIA
#71BIOMARKERS AND METHODS OF TREATING PD-1 AND PD-L1 RELATED CONDITIONS
#72DEVICE AND METHOD FOR DETECTING INFLAMMATION
#73Methods of prognosis and treatment
#74METHOD FOR THE DETECTION OF PROSTATE CANCER
#75Early diagnosis of infections
#76METHOD FOR THE DETECTION OF CANCER
#77MARKER FOR STATIN TREATMENT STRATIFICATION IN HEART FAILURE
#78EXOSOME ASSAY FOR DEPRESSION AND PSYCHOSIS AND METHODS AND AGENTS FOR TREATING DEPRESSION, PSYCHOSIS AND SCHIZOPHRENIA
#79Nanosensors and use thereof
#80Gene expression markers and treatment of multiple sclerosis
#81METHOD FOR DETECTING IMMINENT CHILDBIRTH
#82IL-6 SIGNALING AND BREAST CANCER
#83Vagus nerve stimulation pre-screening test
#84Protein signatures for distinguishing between bacterial and viral infections
#85BIOMARKER PANELS FOR ON-TREATMENT PREDICTION OF RESPONSE TO IMMUNO-ONCOLOGY DRUGS
#86METHOD FOR ASSESSING THE ABILITY OF A SUBSTANCE OR OF A COMPOSITION TO PREVENT, SLOW OR ELIMINATE THE SIGNS OF AGEING OF THE SKIN OR OF THE LIPS
#87Methods of Treating an Autoimmune Disease with a Human Interleukin-3 (IL-3)-Diphtheria Toxin Conjugate (DT-IL3)
#88METHOD FOR EVALUATING THE ABILITY OF A COMPOSITION TO PREVENT MUSCLE DAMAGE AND FATIGUE; FOOD SUPPLEMENT AND DRUG
#89Materials and Methods for Improved Prediction of IGG Therapeutic Protein Exposure
#90SIMULTANEOUS DETECTION OF HUMORAL AND INFLAMMATORY BIOMARKERS
#91METHODS, KITS AND COMPOSITIONS FOR CHARACTERIZING AN ANTI-INFLAMMATORY RESPONSE OF A PRODUCT
#92Method, Systems, and a Kit for Detection, Diagnosis, Monitoring and Treatment of COVID-19
#93CONTROLLED RELEASE OF ANTIBODIES TO MODULATE CYTOKINES
#94Atypical hemolytic uremic syndrome (AHUS) biomarker proteins
#95Methods of prognosis and treatment
#96METHODS FOR TREATING AND REDUCING TRAUMATIC BRAIN INJURY- ASSOCIATED IMPAIRMENTS USING SGP130
#97METHOD FOR DIAGNOSING LIVER DISEASES AND METHOD FOR SCREENING THERAPEUTIC AGENT FOR LIVER DISEASES USING CHANGES IN EXPRESSION OF TM4SF5 PROTEIN
#98Classification of periodontitis patients
#99DIAGNOSIS AND TREATMENT OF IMMUNOTHERAPY-INDUCED NEUROTOXICITY
#100METHODS AND APPARATUS FOR CONDUCTING MULTIPLE MEASUREMENTS ON A SAMPLE
#101METHODS AND COMPOSITIONS FOR ENHANCING IMMUNOASSAYS
#102Cancer chemoprevention with STAT3 blockers
#103Biomarkers for graft-versus-host disease
#104Pencil-like optical fiber sensor probe, portable immunosensor and use thereof
#105Diagnosis of sepsis
#106Selective peptide antagonists
#107METHODS AND KITS FOR EVALUATING CLINICAL OUTCOMES OF AUTOIMMUNE DISEASE
#108Biomarkers and Methods for Measuring and Monitoring Inflammatory Disease Activity
#109MODULATION OF SPLENOCYTES IN CELL THERAPY
#110Use of the IL-6 gene expression level for classification of a subject in risk groups in the prognosis or diagnosis of type II diabetes mellitus
#111Diagnosis and risk stratification of fungal infections
#112ASTROCYTE EXOSOME COMPLEMENT-BASED ASSAY FOR NEUROINFLAMMATION IN ALZHEIMER'S DISEASE AND USES THEREOF
#113ANTI-INFLAMMATORY COMPOSITIONS, METHODS AND USES THEREOF
#114Biomarkers related to organ function
#115Biomarkers for risk assessment and treatment monitoring in heart failure patients guided by natriuretic peptides
#116URINARY TRACT INFECTION DIAGNOSTIC
#117METHOD FOR EVALUATING EFFECT OF CYTOKINE ON METABOLIC ACTIVITY OF CYTOCHROME P450, AND DRUG SCREENING METHOD
#118BIOMARKERS IN EX VIVO LUNG PERFUSION (EVLP) PERFUSATE
#119METHOD AND KIT FOR DIAGNOSIS OF MUSCLE WEAKNESS-RELATED DISEASES USING BLOOD BIOMARKER
#120IL-6 signaling and breast cancer
#121INHIBITORS OF PROTEINS SPECIFIC FOR THE SECRETOME OF A CHONDROCYTE FOR USE IN THE TREATMENT OF BREAST CANCER METASTASIS
#122Methods and compositions for treating subjects having rheumatoid arthritis
#123Methods for assessing treatment with a gastrointestinal implant
#124Diagnostics of mild or advanced periodontitis based on salivary IL-1BETA and MMP-9
#125Method for treating rheumatoid arthritis
#126Compounds
#127Methods of diagnosing and predicting renal disease
#128Use of IGFBP-7 in the assessment of heart failure
#129Biomarker Panel For Diagnosing Cancer
#130Target tissue-specific antigen-binding molecule
#131MATERIAL AND METHODS FOR DIAGNOSING AND TREATING KAWASAKI DISEASE AND KLS
#132Methods of prognosis and treatment
#133METHODS AND APPARATUS FOR CONDUCTING MULTIPLE MEASUREMENTS ON A SAMPLE
#134Early diagnosis of infections
#135Blood Test for Screening Out Amyloid and Alzheimers Disease Presence
#136PREDICTIVE BIOMARKERS OF CLINICAL RESPONSE TO ANTI-LPS IMMUNOGLOBULIN TREATMENT
#137METHOD OF TREATMENT AND PROGNOSIS
#138Method for evaluating the ability of a composition to prevent muscle damage and fatigue; food supplement and drug
#139Marker for statin treatment stratification in heart failure
#140DETECTING SEPSIS
#141PPAR AGONIST OR LXR AGONIST FOR USE IN THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS BY MODULATION OF LAP ACTIVITY
#142Protein signatures for distinguishing between bacterial and viral infections
#143Methods for detecting, diagnosing and treating ulcerative interstitial cystitis
#144BIOMARKERS
#145METHOD FOR DETECTING IMMINENT CHILDBIRTH
#146System for detecting infection in synovial fluid
#147Vagus nerve stimulation pre-screening test
#148Signatures and determinants for diagnosing infections in non-human subjects and methods of use thereof
#149BIOLOGICAL MATERIALS AND USES THEREOF
#150Diagnostic markers of immunosenescence and methods for determining the susceptibility to nosocomial infections
#151Diagnostic Test with Lateral Flow Test Strip
#152Selective peptide antagonists
#153Method for diagnosing and treating fibromyalgia
#154SYSTEM, METHOD AND COMPUTER PROGRAM PRODUCT FOR THE ORGANISM-SPECIFIC DIAGNOSIS OF SEPTICEMIA IN INFANTS
#155CONSTRUCTION METHOD OF CELL MODELS FOR DETECTING PYROGENS, CELL MODELS AND PYROGEN DETECTION KITS
#156Composition for modulating IRAK1
#157Methods and compositions for enhancing immunoassays
#158DIAGNOSTIC ASSAYS FOR SUPAR-β3 INTEGRIN DRIVEN KIDNEY DISEASES
#159Modulation of splenocytes in cell therapy
#160Methods of identifying schizophrenia patients at risk for relapse
#161IL-6 signaling and breast cancer
#162Molecular probe for signal amplification and kit and assay using the same
#163BIOMARKER FOR PSYCHIATRIC AND NEUROLOGICAL DISORDERS
#164Predictive biomarkers of clinical response to anti-LPS immunoglobulin treatment
#165Biomarker panel for diagnosing cancer
#166Gene expression markers and treatment of multiple sclerosis
#167HOMOGENOUS AND HETEROGENEOUS ASSAYS AND SYSTEMS FOR DETERMINATION OF OCULAR BIOMARKERS
#168Method for treating chronic intestinal inflammation and inflammatory bowel disease by administering antagonists of Oncostatin-M (OSM) and/or antagonists of OSM receptor-beta (OSMR)
#169Biological Materials and Uses Thereof
#170Methods of diagnosing and predicting renal disease
#171METHOD AND DEVICE FOR QUANTIFICATION OF TARGET MOLECULES
#172Compositions and methods for the prevention and treatment of mast cell-induced vascular leakage
#173ATYPICAL HEMOLYTIC UREMIC SYNDROME (AHUS) BIOMARKER PROTEINS
#174Method and panel for determining acute kidney injury
#175SIGNATURES AND DETERMINANTS FOR DIAGNOSING INFECTIONS IN NON-HUMAN SUBJECTS AND METHODS OF USE THEREOF
#176Method for treating rheumatoid arthritis
#177METHOD FOR PRODUCING AUTOLOGOUS TOLEROGENIC DENDRITIC CELLS (TOLDCS) WITH SPECIFIC ANTIGENS AND THEIR USE IN THE PREPARATION OF A MEDICAMENT USEFUL FOR THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
#178Biomarker-based methods for aiding the diagnosis of stroke
#179Biomarkers and Methods for Measuring and Monitoring Inflammatory Disease Activity
#180CANCER CELL MIGRATION INHIBITORS AND THEIR USE IN THERAPEUTIC TREATMENTS
#181Methods of aiding in the diagnosis of diseases using anti-IL-6 antibodies
#182Polypeptide
#183Diagnosis of urothelial cancer
#184TnT BASED DIAGNOSIS OF PAROXYSMAL ATRIAL FIBRILLATION
#185Method for treating muscular dystrophy
#186METHODS FOR DIAGNOSIS AND PROGNOSIS OF INFLAMMATORY BOWEL DISEASE USING CYTOKINE PROFILES
#187Atypical hemolytic uremic syndrome (aHUS) biomarker proteins
#188Use of IGFBP-7 in the assessment of heart failure
#189MATERIALS AND METHODS FOR THE TREATMENT OF CELIAC DISEASE
#190Herbal Combinations for Treating Eczema
#191CARBOHYDRATE-MODIFIED PARTICLES AND PARTICULATE FORMULATIONS FOR MODULATING AN IMMUNE RESPONSE
#192Biomarkers for risk assessment and treatment monitoring in heart failure patients guided by natriuretic peptides
#193Methods of developing selective peptide antagonists
#194IL-6 detection based early diagnosis and prediction of systemic inflammatory response syndrome and sepsis in asymptomatic patients
#195METHODS FOR DIAGNOSING, SCREENING, IDENTIFYING, MONITORING, AND TREATING ADVERSE LOCAL TISSUE REACTIONS, WHICH LEAD TO FAILURE OF ORTHOPEDIC IMPLANTS
#196METHODS AND APPARATUS FOR CONDUCTING MULTIPLE MEASUREMENTS ON A SAMPLE
#197Biomarkers related to organ function
#198PROTECTION OF TCR SIGNALING CHAINS IN CANCER PATIENTS AND ENHANCEMENT OF CAR-T CELL THERAPY
#199Biomarkers and methods of treating PD-1 and PD-L1 related conditions
#200ANTI-INFLAMMATORY COMPOSITIONS, METHODS AND USES THEREOF
#201Gene and protein expression properties of adherent stromal cells cultured in 3D
#202METHODS AND COMPOSITIONS FOR THE TREATMENT AND DIAGNOSIS OF DISEASES CHARACTERIZED BY VASCULAR LEAK, HYPOTENSION, OR A PROCOAGULANT STATE
#203Suppression of cytokine release and cytokine storm
#204Marker for statin treatment stratification in heart failure
#205Diagnosis of sepsis
#206Atypical hemolytic uremic syndrome (AHUS) biomarker proteins
#207STRESS AND INFLAMMATION BIOMARKER URINE PANEL FOR DAIRY COWS AND BEEF CATTLE
#208Antibody and Cytokine Biomarker Profiling for Determination of Patient Responsiveness
#209Method for aiding differential diagnosis of stroke
#210BIOMARKERS FOR THE DIAGNOSIS AND THE RESPONSE TO TREATMENT OF PANCREATIC CANCER
#211Method for predicting post-therapy prognosis of relapsing-remitting multiple sclerosis (RRMS) patient, and method for determining applicability of novel therapy
#212Biomarker for psychiatric and neurological disorders
#213COMPOSITIONS FOR OVARIAN CANCER ASSESSMENT HAVING IMPROVED SPECIFICTY
#214Carbohydrate Compounds for Nutritional and Therapeutic Use
#215Detection of intraamniotic and/or infection
#216Inhibitors of proteins specific for the secretome of a chondrocyte for use in the treatment of breast cancer metastasis
#217Biological Materials and Uses Thereof
#218Pre-eclampsia biomarkers
#219PROCESS FOR THE MEASUREMENT OF THE POTENCY OF GLATIRAMER ACETATE
#220Process for assessing risk of substance administration
#221Method and kit for cytokine analysis from a human whole blood sample
#222Methods for determining risk of chronic lung allograft dysfunction (CLAD) and subtypes thereof
#223Biomarkers and methods for measuring and monitoring inflammatory disease activity
#224EFFECTOR T CELL RSISTANCE
#225Biomarkers for the identification of liver damage
#226Method for diagnosing fibromyalgia
#227COMPOSITIONS AND METHODS RELATED TO DORMANT SENESCENCE-PRONE CELLS (DSPC)
#228Monocyte activation test better able to detect non-endotoxin pyrogenic contaminants in medical products
#229Method for evaluating effect of cytokine on metabolic activity of cytochrome P450, and drug screening method
#230Diagnosis and risk stratification of bladder cancer
#231MATERIAL AND METHODS FOR DIAGNOSING AND TREATING KAWASAKI DISEASE AND KLS
#232VAGUS NERVE STIMULATION SCREENING TEST
#233TnT BASED DIAGNOSIS OF PAROXYSMAL ATRIAL FIBRILLATION
#234Use of a panel of urinary cytokines to predict response to BCG therapy for bladder cancer
#235IN VITRO ASSAY FOR PREDICTING RENAL PROXIMAL TUBULAR CELL TOXICITY
#236TARGET TISSUE-SPECIFIC ANTIGEN-BINDING MOLECULE
#237CANCER PROGNOSTIC ASSAYS
#238Methods and devices for tuberculosis diagnosis using biomarker profiles
#239Methods of assessing the immunomodulatory potential of a multipotent stromal cell (MSC) population, and systems and kits for practicing the same
#240BIOMARKERS FOR LOWER URINARY TRACT SYMPTOMS (LUTS)
#241Biomarkers
#242Retrieval of biological materials from the human uterus, ovary and cervix by suction
#243Compositions and methods for the prevention and treatment of mast cell-induced vascular leakage
#244System for detecting infection in synovial fluid
#245ASSAYS AND METHODS FOR THE DIAGNOSIS OF OVARIAN CANCER
#246Biomarkers for Tuberculosis and HIV/AIDS
#247Single Molecule Assays
#248RISK PREDICTORS FOR ADVERSE PERINATAL OUTCOMES
#249METHOD FOR DIAGNOSING AND TREATING FIBROMYALGIA
#250Methods and compositions for enhancing immunoassays
#251Highly sensitive biomarker panels
#252IL-6 DETECTION BASED EARLY DIAGNOSIS AND PREDICTION OF SYSTEMATIC INFLAMMATORY RESPONSE SYNDROME AND SEPSIS IN ASYMPTOMATIC PATIENTS
#253Biomarker panels for assessing radiation injury and exposure
#254MOLECULAR MARKER FOR EVALUATING PATHOLOGICAL CONDITIONS AND TREATMENT OF MUSCULAR DYSTROPHY
#255PROCESS FOR THE MEASUREMENT OF THE POTENCY OF GLATIRAMER ACETATE
#256Compounds
#257Obesity Dependent Adipokine Biomarkers for Prostate Cancer
#258INDICATOR AGENT FOR NONINFLAMMATORY STRESS RESPONSE AND USE THEREOF
#259DIAGNOSTIC METHOD FOR DETECTING CANCER BY MEASURING AMOUNT OF A CYTOKINE LIKE IL-6
#260Methods and compositions of nucleic acid ligands for detection of clinical analytes related to human health
#261Materials and methods for the treatment of celiac disease
#262Monocyte activation test better able to detect non-endotoxin pyrogenic contaminants in medical products
#263Use of IL-27-P28 to antagonize IL-6 mediated signaling
#264BIOMARKERS FOR PREDICTING SUSTAINED RESPONSE TO HCV TREATMENT
#265Modulation of splenocytes in cell therapy
#266Combination therapy and method for assessing resistance to treatment
#267Methods of diagnosing and predicting renal disease
#268TREATMENT OF POMPE DISEASE WITH SPECIFIC PHARMACOLOGICAL CHAPERONES AND MONITORING TREATMENT USING SURROGATE MARkERS
#269Process for the measurement of the potency of glatiramer acetate
#270Detection of intraamniotic infection
#271Biomarkers and methods for measuring and monitoring inflammatory disease activity
#272Assay for diagnosis of cardiac myocyte damage
#273Methods and apparatus for conducting multiple measurements on a sample
#274DIAGNOSIS OF SEPSIS
#275METHODS FOR DIAGNOSING DIABETES AND DETERMINING EFFECTIVENESS OF TREATMENTS
#276Methods of treating autism spectrum disorders and compositions for same
#277Highly sensitive biomarker panels
#278USE OF IGFBP-7 IN THE ASSESSMENT OF HEART FAILURE
#279Method for assessing risk of heart failure
#280ASSAYS FOR DETERMINING EXPOSURE TO MULTIWALLED CARBON NANOTUBES
#281MARKER FOR ARRHYTHMIA RISK
#282METHODS AND COMPOSITIONS FOR THE TREATMENT AND DIAGNOSIS OF DISEASES CHARACTERIZED BY VASCULAR LEAK, HYPOTENSION, OR A PROCOAGULANT STATE
#283Monocyte activation test better able to detect non-endotoxin pyrogenic contaminants in medical products
#284Monocyte activation test better able to detect non-endotoxin pyrogenic contaminants in medical products
#285Making a prognosis in cases of cardiac disease using a combination of markers
#286METHOD OF DETECTING CEREBRAL STROKE OR ASYMPTOMATIC CEREBRAL INFARCTION USING ACROLEIN, INTERLEUKIN-6 AND CRP CONTENTS, POLYAMINE OXIDASE ACTIVITY OR POLYAMINE OXIDASE PROTEIN CONTENT AND SUBJECT'S AGE AS INDICATORS
#287Methods of treating or diagnosing conditions associated with elevated IL-6 using anti-IL-6 antibodies or fragments
#288SINGLE MOLECULE ASSAYS
#289Development of Diagnostic Markers From the Saliva of Head and Neck Cancer Patients
#2904-1 bb ligand in inflammatory diseases
#291THERAPEUTIC COMPOSITION COMPRISING AN INHIBITOR OF AN HSP 90 PROTEIN
#292Method for detecting IL-16 activity and modulation of IL-16 activity based on rantes proxy protein levels
#293Methods for Screening Interleukin-6 (IL-6) Signal Transduction Inhibitors
#294Assessing risk of disease progression in rheumatoid arthritis patients
#295PERITONEAL DIALYSIS SOLUTION TEST METHOD
#296METHODS FOR MEASURING PRO-INFLAMMATORY SUBSTANCE LEVELS IN DIALYSIS SOLUTIONS AND DIALYSIS COMPONENTS
#297Method and kit for diagnosing acute myocardial infarction
#298Biomarkers for the diagnosis of autoimmune disease
#299MOLECULE AND CHIMERIC MOLECULES THEREOF
#300MARKER FOR ARRHYTHMIA RISK